Hypertension, hypertrophy, heart failure

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Hypertension, hypertrophy, heart failure

Abstract

References

Prognosis after acute myocardial infarction: relation to blood pressure values before infarction in a prospective cardiovascular study

Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions

The heart in hypertension

Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension)

Impact of left ventricular hypertrophy on ventricular arrhythmias in the absence of coronary artery disease

Influence of contemporary versus 30-year blood pressure levels on left ventricular mass and geometry: the Framingham Heart Study

Drug-induced modification of vascular structure: effects of antihypertensive drugs

Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study

Trends in hospitalization rates for heart failure in the United States, 1973-1986. Evidence for increasing population prevalence.

Changes in hypertension treatment and in congestive heart failure mortality in the United States

Arrhythmogenic effect of high blood pressure: some observations on its mechanism

Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly trial

Quality of life in early heart failure. The study of men born in 1913

Diagnostic heterogeneity in clinical trials for congestive heart failure

Does hypertension predispose to coronary disease? Conflicting epidemiological and experimental evidence

Role of blood pressure in the development of congestive heart failure. The Framingham study

Effects of treatment on morbidity in hypertension. 3. Influence of age, diastolic pressure, and prior cardiovascular disease; further analysis of side effects

Sudden death, hypertension, and hypertrophy

Epidemiologic features of chronic atrial fibrillation: the Framingham study

Blood pressure and survival after myocardial infarction: the Framingham study

Disparate effects of antihypertensive drugs on large artery distensibility and compliance in hypertension

Blood pressure and end-stage renal disease in men

The cardiac renin-angiotensin-aldosterone system and hypertensive cardiac hypertrophy

Systolic ventricular dysfunction and heart failure due to coronary microangiopathy in hypertensive heart disease

Hospitalization for congestive heart failure. Explaining racial differences

Framingham study insights into hypertensive risk of cardiovascular disease

Prevalence, clinical features and prognosis of diastolic heart failure: an epidemiologic perspective

Rapid transcriptional activation and early mRNA turnover of brain natriuretic peptide in cardiocyte hypertrophy. Evidence for brain natriuretic peptide as an "emergency" cardiac hormone against ventricular overload

Effect of antihypertensive treatment on small arteries of patients with previously untreated essential hypertension

Q-wave regression unrelated to patency of infarct-related artery or left ventricular ejection fraction or volume after anterior wall acute myocardial infarction treated with or without reperfusion therapy

Comparison of five antihypertensive monotherapies and placebo for change in left ventricular mass in patients receiving nutritional-hygienic therapy in the Treatment of Mild Hypertension Study (TOMHS)

Heart failure: a growing public health problem

Role of ACE inhibitors in hypertension with left ventricular hypertrophy

Report of the Task Force on Research in Heart Failure

Plasma brain natriuretic peptide as an indicator for angiotensin-converting-enzyme inhibition after myocardial infarction

Comparison of classification of the severity of hypertension by blood pressure level and by World Health Organization criteria in the prediction of concurrent cardiac abnormalities and subsequent complications in essential hypertension

Cardioreparation and the concept of modulating cardiovascular structure and function

The natural history of borderline isolated systolic hypertension

1993 guidelines for the management of mild hypertension: memorandum from a World Health Organization/International Society of Hypertension meeting. Guidelines Sub-Committee

Survival after the onset of congestive heart failure in Framingham Heart Study subjects

Spectrum and outcome of congestive heart failure in a hospitalized population

Heart failure in the 1990s: evolution of a major public health problem in cardiovascular medicine

The epidemiology of heart failure: the Framingham Study

Asymptomatic ventricular arrhythmias and mortality risk in subjects with left ventricular hypertrophy

The fifth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V)

Progressive left ventricular dysfunction and remodeling after myocardial infarction. Potential mechanisms and early predictors

Management guidelines in essential hypertension: report of the second working party of the British Hypertension Society

Cardiac transplantation

The effect of enalapril on mortal and morbid events in patients with hypertension and left ventricular dysfunction

Citations

Is hypertension a leading cause of heart failure in Chinese?

Angiotensin II type-I receptor antagonists in the treatment of heart failure

Blood Pressure and the Risk of Death From Non-cardiovascular Diseases: A Population-based Cohort Study of Korean Adults

Hypertension--still an important cause of heart failure?

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Related Papers

Increase in hospital admission rates for heart failure in The Netherlands, 1980-1993

Antipsychotic medications and cardiac conduction risks

Heart rate recovery after exercise and long-term prognosis in patients with coronary artery disease

Current role of contrast echocardiography in the diagnosis of cardiovascular diseases

Effects of angiotensin II generated by an angiotensin converting enzyme-independent pathway on left ventricular performance in the conscious baboon